Agitation & Alzheimer's Disease (AAD) Archives - Page 2 of 6

The Agitation in Alzheimer’s Screener For Caregivers (AASC™) – A New Tool To Disease Recognition

Live Event September 26, 2024 6:30 pm to 8:00 pm CDT

Amaka Onyereri, PharmD, BCPS (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event September 17, 2024 6:30 pm to 8:00 pm CDT

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22, 2024 6:30 pm to 8:30 pm CDT

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 22, 2024 6:00 pm to 9:00 pm CDT

Linzy Hendrickson, PhD (OPDC) is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Clinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community

Webinar September 18, 2024 12:00 pm to 1:00 pm EDT

Freddi Segal-Gidan, PA PhD is a volunteer and has declined payment for this activity. Daniel Jimenez, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. John Awad,… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event August 20, 2024 6:00 pm to 8:00 pm EDT

Speaker Lindsey Wright, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Live Event October 30, 2024 6:00 pm to 8:00 pm CDT

Speaker Kavita Parikh, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Live Event May 21, 2024 6:00 pm to 7:00 pm CDT

Speakers Kavita Saini, PharmD and Christian Aurup, Phd are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental… Read More

Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Live Event June 4, 2024 6:30 pm to 8:30 pm CDT

Speakers Amaka Onyereri, PharmD, BCPS and Hasib H. Bhojwani, MD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka… Read More

Testing Event – WP SMTP Delay

Live Event April 11, 2024 4:00 pm to 8:00 pm EDT

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community;… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: